Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension
- 15 November 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (1) , 123-126
- https://doi.org/10.1016/j.amjcard.2005.07.129
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- End points and clinical trial designs in pulmonary arterial hypertensionJournal of the American College of Cardiology, 2004
- The 6-minute walk test: How important is the learning effect?American Heart Journal, 2003
- Beraprost therapy for pulmonary arterial hypertensionJournal of the American College of Cardiology, 2003
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Bosentan Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2002
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- The body weight–walking distance product as related to lung function, anaerobic threshold and peakV̇O2in COPD patientsRespiratory Medicine, 2001
- Comparing correlated but nonoverlapping correlations.Psychological Methods, 1996
- Comparing correlated correlation coefficients.Psychological Bulletin, 1992